Cargando…
Mobile Health Solutions for Prostate Cancer Diagnostics—A Systematic Review
Prostate cancer, the most common cause of cancer in men in the UK and one of the most common around the world to date, has no consensus on screening. Multiple large-scale trials from around the world have produced conflicting outcomes in cancer-specific and overall mortality. A main part of the issu...
Autores principales: | Moghul, Masood, Cazzaniga, Walter, Croft, Fionnuala, Kinsella, Netty, Cahill, Declan, James, Nicholas David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453449/ https://www.ncbi.nlm.nih.gov/pubmed/37623259 http://dx.doi.org/10.3390/clinpract13040078 |
Ejemplares similares
-
COmparing Urolift and Standard Transurethral resection of prostate Ahead of Radiotherapy in men with urinary symptoms secondary to prostate enlargement in Southwest London and North Cumbria (CO-STAR): a study protocol for a randomised feasibility study
por: Wong, Kathie, et al.
Publicado: (2023) -
Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices
por: Kinsella, Netty, et al.
Publicado: (2018) -
Developing a consensus statement for psychosocial support in active surveillance for prostate cancer
por: Beckmann, Kerri, et al.
Publicado: (2022) -
Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer
por: Beckmann, Kerri, et al.
Publicado: (2021) -
Detection rates of recurrent prostate cancer: (68)Gallium (Ga)-labelled prostate-specific membrane antigen versus choline PET/CT scans. A systematic review
por: Moghul, Masood, et al.
Publicado: (2019)